Phytocannabinoids: a new frontier in Alzheimer’s disease management
Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by cognitive decline and behavioral disturbances. The pathogenic characteristics encompass the existence of amyloid plaques outside the cells, neurofibrillary tangles inside the cells, neuroinflammation, oxidative stre...
Saved in:
| Main Author: | Jagadeesh S. Rao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Academia.edu Journals
2024-09-01
|
| Series: | Academia Biology |
| Online Access: | https://www.academia.edu/124103477/Phytocannabinoids_a_new_frontier_in_Alzheimer_s_disease_management |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Recent Preclinical Evidence on Phytocannabinoids in Neurodegenerative Disorders: A Focus on Parkinson’s and Alzheimer’s Disease
by: Nicoleta-Mirela Blebea, et al.
Published: (2025-06-01) -
Pharmacokinetics of Non-Psychotropic Phytocannabinoids
by: Mariana Lacerda, et al.
Published: (2025-02-01) -
Phytocannabinoids as Chemotherapy Adjuncts—A Review for Users
by: Gerhard Nahler
Published: (2024-10-01) -
Exploring the Potential of Phytocannabinoids Against Multidrug-Resistant Bacteria
by: Carmina Sirignano, et al.
Published: (2025-06-01) -
Treatment of Migraine With Phytocannabinoids, the Involvement of Endocannabinoids in Migraine, and Potential Mechanisms of Action
by: Roger Gregory Biringer
Published: (2025-01-01)